Equity Overview
Price & Market Data
Price: $21.09
Daily Change: -$1.29 / 6.12%
Range: $20.61 - $22.07
Market Cap: $393,596,352
Volume: 201,688
Performance Metrics
1 Week: 23.91%
1 Month: 10.94%
3 Months: -54.88%
6 Months: -41.92%
1 Year: 45.25%
YTD: -54.32%
Company Details
Employees: 51
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein-coupled receptors (GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is headquartered in Watertown, Massachusetts.